WENDY PERRY: Open Payments
NPI 1033673132 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$357 in 12 payments from 8 companies in 2025. Trend: 2023 $713 · 2024 $567 · 2025 $357
Food & beverage: $357
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 1 | $124 |
| ABBVIE INC. | 4 | $113 |
| SHIELD THERAPEUTICS INC | 2 | $30 |
| GlaxoSmithKline, LLC. | 1 | $24 |
| Axsome Therapeutics, Inc. | 1 | $19 |
| Novo Nordisk Inc | 1 | $18 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $14 |
| Corcept Therapeutics | 1 | $14 |
Products named: OPDIVO, QULIPTA, UBRELVY, ACCRUFER, TRELEGY ELLIPTA, Auvelity, RELISTOR, Korlym.
Industry payments across CT — which companies pay providers there.
